Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Chicago
Emory University
City of Hope Medical Center
University of Chicago
Ohio State University Comprehensive Cancer Center
University of Utah
Centre Hospitalier Universitaire Vaudois
University of California, San Francisco
OX2 Therapeutics